Report : Europe Intracranial Pressure Monitoring Devices Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Offering (Products & Systems, Solutions & Platforms, and Services), Type (Invasive and Non-Invasive), Application (Traumatic Brain Injuries, Reye’s Syndrome, Non-Traumatic Bleeds, Hydrocephalus, Space-Occupying Lesions, Cerebral Oedema, and Others), and End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others)
At 6.5% CAGR, the Europe Intracranial pressure monitoring Devices Market is speculated to be worth US$ 812.90 million by 2028, says The Business Market Insights
According to the Business Market Insights’ research, the Europe intracranial pressure monitoring devices market was valued at US$ 594.28 million in 2023 and is expected to reach US$ 812.90 million by 2028, registering a CAGR of 6.5% from 2023 to 2028. Increasing prevalence of neurological diseases and rising incidence of traumatic brain injuries (tbis) are the critical factors attributed to the Europe intracranial pressure monitoring devices market expansion.
Intracranial pressure (ICP) monitoring is crucial in diagnosing and treating neurological diseases such as subarachnoid and intracerebral hemorrhage, ischemic stroke, hydrocephalus, and meningitis/encephalitis. Bleeding in the brain, tumor, stroke, aneurysm, high blood pressure, or brain infection can lead to fluctuations in intracranial pressure. High ICP can cause headaches, blurred vision, vomiting, and other serious complications such as seizures, neurological damage, and death. According to the Europe Stroke Fact Sheet 2022, there are over 7.6 million new ischemic stroke cases yearly, and over 62% of all incident strokes are ischemic strokes. Around 11% of all ischemic stroke cases occur in patients aged 15–49 years, and more than 58% occur in people under 70. Also, 55% of all ischemic stroke cases occur in women and 45% in men. Thus, the increasing prevalence of neurological diseases drives the growth of the Europe Intracranial pressure monitoring devices market.
On the contrary, limitations associated with ICP monitors hurdles the growth of Europe intracranial pressure monitoring devices market.
Based on offering, the Europe intracranial pressure monitoring devices market is segmented into product & systems, solutions & platform, and services. The products and systems held 69.0% market share in 2023, amassing US$ 409.98 million. It is projected to garner US$ 553.13 million by 2028 to expand at 6.2% CAGR during 2023–2028.
Based on type, the Europe intracranial pressure monitoring devices market is segmented into invasive and non-invasive. The invasive segment held 82.4% market share in 2023, amassing US$ 489.72 million. It is projected to garner US$ 663.82 million by 2028 to expand at 6.3% CAGR during 2023–2028.
Based on applications, the Europe intracranial pressure monitoring devices market is segmented into traumatic brain injuries, reye’s syndrome, non-traumatic bleeds, hydrocephalus, space-occupying lesions, cerebral oedema, and others. The traumatic brain injuries held 36.5% market share in 2023, amassing US$ 217.06 million. It is projected to garner US$ 293.79 million by 2028 to expand at 6.2% CAGR during 2023–2028.
Based on end user, the Europe intracranial pressure monitoring devices market is segmented into hospitals, clinics, ambulatory surgical centers, and others. The hospitals segment held 59.4% market share in 2023, amassing US$ 353.26 million. It is projected to garner US$ 479.98 million by 2028 to expand at 6.3% CAGR during 2020–2028.
Based on country, the Europe intracranial pressure monitoring devices market is segmented into the UK, Germany, Italy, France, Spain, and the Rest of Europe. Our regional analysis states that Germany captured 29.3% market share in 2023. It was assessed at US$ 174.36 million in 2023 and is likely to hit US$ 234.03 million by 2028, exhibiting a CAGR of 6.1% during the forecast period.
Key players dominating the Europe intracranial pressure monitoring devices market are RAUMEDIC AG; Sophysa SA; Integra LifeSciences Holdings Corp; Medtronic Plc; Braincare Desenvolvimento e Inovacao Tecnologica SA; NovaSignal Corp; Digitimer Ltd; and Spiegelberg GmbH & Co KG among others.
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@businessmarketinsights.com